Cargando…
Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212399/ https://www.ncbi.nlm.nih.gov/pubmed/35724754 http://dx.doi.org/10.1016/j.jinf.2022.06.012 |
| _version_ | 1784730579552436224 |
|---|---|
| author | Cochino, Alexis Virgil Farkas, Oana Maria Ioan, Andreea |
| author_facet | Cochino, Alexis Virgil Farkas, Oana Maria Ioan, Andreea |
| author_sort | Cochino, Alexis Virgil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212399 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92123992022-06-22 Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure Cochino, Alexis Virgil Farkas, Oana Maria Ioan, Andreea J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-09 2022-06-18 /pmc/articles/PMC9212399/ /pubmed/35724754 http://dx.doi.org/10.1016/j.jinf.2022.06.012 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Cochino, Alexis Virgil Farkas, Oana Maria Ioan, Andreea Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure |
| title | Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure |
| title_full | Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure |
| title_fullStr | Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure |
| title_full_unstemmed | Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure |
| title_short | Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure |
| title_sort | pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe covid-19 and no increase in flare rate after sars cov-2 exposure |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212399/ https://www.ncbi.nlm.nih.gov/pubmed/35724754 http://dx.doi.org/10.1016/j.jinf.2022.06.012 |
| work_keys_str_mv | AT cochinoalexisvirgil pediatricpatientswithimmunemediateddiseasesonimmunosuppressantshavelowriskofseverecovid19andnoincreaseinflarerateaftersarscov2exposure AT farkasoanamaria pediatricpatientswithimmunemediateddiseasesonimmunosuppressantshavelowriskofseverecovid19andnoincreaseinflarerateaftersarscov2exposure AT ioanandreea pediatricpatientswithimmunemediateddiseasesonimmunosuppressantshavelowriskofseverecovid19andnoincreaseinflarerateaftersarscov2exposure |